Prof Mark Jenkins
Professor in Epidemiology, MEGA
Melbourne School of Population and Global Health
900 Scholarly works
73 Projects
HIGHLIGHTS
2026
Journal article
Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes
DOI: 10.1186/s12885-025-15440-x2026
Journal article
Effective General Practice-Led Interventions to Increase Uptake in Colorectal Cancer Screening: A Scoping Review
DOI: 10.1097/PHH.00000000000023672026
Journal article
Risk Factors for Subsequent Primary Cancers in Colorectal Cancer Survivors: A Systematic Review and Meta-analysis.
DOI: 10.1158/1055-9965.EPI-26-03862026
Research contracts (non-grants)
Testing Interventions to Increase Participation in the Australian National Bowel Cancer Screening Program Among Persistent Never-Screeners: Study Protocol for a Randomised Controlled Trial
2023
Research grants (ARC, NHMRC, MRFF)
The CASSOWARY Trial: An RCT of the Clinical Utility and Cost-Effectiveness of a Multi-Cancer Polygenic Risk Score in General Practice.
2018
Research grants (international)
Colon Cancer Family Registry Cohort
2018
Journal article
Breast cancer risk associations with digital mammographic density by pixel brightness threshold and mammographic system
DOI: 10.1148/radiol.2017170306
RECENT SCHOLARLY WORKS
2026
Journal article
Alcohol consumption and molecular subtypes of colorectal cancer: pooled observational and Mendelian randomization analyses
DOI: 10.1016/j.ajcnut.2026.1013082026
Journal article
Optimising SMS content for bowel cancer screening participation in Australia: cross-sectional national survey findings
DOI: 10.1071/PU251212026
Journal article
Tumor mutational and microbial profiles of early-onset and later-onset colorectal cancers according to detailed tumor location: an international pooled analysis
DOI: 10.1097/js9.00000000000038772026
Journal article
Response to Yu
DOI: 10.1093/jnci/djaf3522026
Journal article
Testing interventions to increase participation in the Australian National Bowel Cancer Screening Program among persistent never-screeners: study protocol for a randomised controlled trial
DOI: 10.1186/s13063-026-09553-22026
Other
HLA Heterozygosity Influences Colorectal Cancer Risk and Survival Outcome
DOI: 10.1053/j.gastro.2025.10.0202026
Journal article
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancers
DOI: 10.1007/s10689-025-00519-y
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
ROSELLA: Implementation of Polygenic Risk Assessment in General Practice for Australias Most Common Cancers